ADVERTISEMENT

KNUST starts clinical trial for its Typhoid vaccines in Agogo

The Kwame Nkrumah University of Science and Technology (KNUST) has started clinical trials for its vaccine for typhoid in Agogo.

Established in 1952, KNUST is one of the best universities in Ghana

The vaccine is produced by the School of Public Health in collaboration with the International Vaccine Institute.

Prof. Yaw Adu Sarkodie Principal Investigator of the project, in addressing the media said they are targeting at least 26,000 children in the trial.

The trial of the Typhoid vaccines will generate additional data to support decision-making and the management of typhoid fever and other causes of fever in the sub-region.

It will further develop solutions to counter poverty-related diseases with a huge economic impact in the sub-region.

ADVERTISEMENT

He explained that they chose the Asante Akim North District and Central District because the district has had a problem with Typhoid disease for years.

He disclosed the university and its partners are developing a number of vaccines including COVID-19 vaccines to combat the viral disease.

The trial vaccination exercise is targeting children above 9 months to 15 years with the expectation of vaccinating about 26,000 children in the Asante Akin North and Central districts.

The programme is being funded by European Developing Countries Clinical Trials Partnership (EDCTP) and the Bill and Melinda Gates Foundation.

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.com.gh

ADVERTISEMENT